Showing results (11-20 of 261) with videos related to
Sort By:
Pageof 27
Best Practice & Research. Clinical Haematology|September 15, 2018
Immunotherapy in aggressive B-cell lymphomasCaron A Jacobson, Philippe ArmandSurgical Oncology Clinics of North America|November 24, 2019
Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: Genetic Classification and Its Implications for Prognosis and TreatmentJennifer L Crombie, Philippe ArmandBritish Journal of Haematology|October 28, 2017
Minimal residual disease in non-Hodgkin lymphoma - current applications and future directionsMatthew L Chase, Philippe ArmandJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2017
Minimal Residual Disease Assessment in Lymphoma: Methods and ApplicationsAlex F Herrera, Philippe ArmandBiology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 24, 2007
Allogeneic stem cell transplantation for aplastic anemiaPhilippe Armand, Joseph H AntinHematology/Oncology Clinics of North America|June 24, 2019
Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: Genetic Classification and Its Implications for Prognosis and TreatmentJennifer L Crombie, Philippe ArmandBlood|September 24, 2024
The current landscape of frontline large B-cell lymphoma trialsDavid Qualls, Philippe Armand, Gilles SallesClinical Lymphoma, Myeloma & Leukemia|June 23, 2026
A Phase I Study of Copanlisib and Venetoclax in Patients With Relapsed or Refractory Diffuse Large B-Cell LymphomaJennifer L Crombie, Austin I Kim, Robert Redd, et al.Leukemia & Lymphoma|January 10, 2020
Checkpoint inhibition therapy as possible frontline therapy for Hodgkin lymphomaArushi Khurana, Philippe Armand, Stephen M AnsellBlood Advances|November 15, 2024
A real-world comparison of commercial-use axicabtagene ciloleucel and lisocabtagene maraleucel in large B-cell lymphomaAndrew Looka, David A Qualls, Daniel Matthews, et al.Pageof 27